Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
2023 · Clinical and Translational Radiation Oncology · 5 citations
https://doi.org/10.1016/j.ctro.2023.100706